Hematology/Oncology

Top Story

Granisetron patch prevents CINV for patients with hematologic malignancies

May 24, 2016

Read the Perspective from David L. Jennings II, MSN, RN, AGPCNP-BC

Granisetron transdermal system patch prevented chemotherapy-induced nausea and vomiting as well as oral granisetron in patients with hematologic malignancies, according to results of a post-hoc analysis presented at the Oncology Nursing Society Annual Congress.

“Despite prophylaxis, chemotherapy-induced nausea and vomiting (CINV), especially during the delayed phase, remains a barrier to attaining planned chemotherapy dose on time for some patients,” Karen A. Pekle, ANP, BS, BSN, MS, nurse practitioner at NewYork-Presbyterian and Weill Cornell Medicine, and colleagues wrote. “A granisetron transdermal system has been shown to be as effective as oral granisetron in controlling CINV across multiple tumor types."

In the Journals

Overweight patients less likely to die of colorectal cancer

May 24, 2016
BMI at the time of colorectal cancer diagnosis is associated with mortality risk, according to results of a retrospective observational study.Patients categorized as…
In the Journals

Geriatric events increase morbidity, costs among older patients who undergo cancer surgery

May 24, 2016
Older individuals who underwent cancer surgery appeared likely to experience geriatric events, such as falls and fractures, delirium and dehydration.These events —…
Meeting News Coverage

Top Takeaways from ASH: Oral anticoagulants shift cancer-related thrombosis treatment paradigm

May 24, 2016
With a range of questions lingering unanswered in the arena of cancer-related thrombosis, new research presented at the ASH Annual Meeting and Exposition armed…
Meeting News CoverageVideo

VIDEO: Smoking cessation more beneficial than lung cancer screening

May 23, 2016
WASHINGTON — David E. Midthun, MD, FACP, professor of medicine and director of the lung cancer screening program at Mayo Clinic, discussed various aspects of lung…
More News Headlines »
CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Video
Meeting News Coverage

VIDEO: Expert discusses controversies in lung cancer screenings

May 13, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan